Adma Biologics reported $1.24M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Adma Biologics USD 1.24M 145K Jun/2026
Alnylam Pharmaceuticals USD 28.14M 1.54M Jun/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Novavax USD 303K 27K Dec/2021
Takeda JPY 14.57B 10.04B Sep/2026